BioCryst Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 67   

Articles published

BCRX 11.27 -0.02 (-0.18%)
price chart
Biotech Stocks Scanner -- Regeneron Pharma, BioCryst Pharma, Spectrum ...
Although BioCryst Pharmaceuticals Inc.'s shares have declined 2.17% in the last three trading sessions, it has surged 35.37% in the previous three months and 48.55% on YTD basis.
Related articles »  
BioCryst Pharmaceuticals Given Average Rating of "Buy" by Analysts (NASDAQ ...
BioCryst Pharmaceuticals logo BioCryst Pharmaceuticals (NASDAQ:BCRX) has earned a consensus rating of �Buy� from the twelve ratings firms that are currently covering the company, Analyst RN reports. Two analysts have rated the stock with a hold ...
Plummets - Sequenom, (NASDAQ:SQNM), SUPERVALU Inc. (NYSE:SVU ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases.
News Buzz - Capstead Mortgage Corporation (CMO), BioCryst Pharmaceuticals ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases.
Related articles »  
Healthcare Volatile Stocks: AcelRx Pharmaceuticals Inc (NASDAQ:ACRX ...
Healthcare Volatile Stocks: AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), BioCryst Pharmaceuticals (NASDAQ:BCRX), Amicus Therapeutics (NASDAQ:FOLD), Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), Seattle Genetics, (NASDAQ:SGEN).
BioCryst Pharmaceuticals Receives Consensus Recommendation of �Buy� from ...
BioCryst Pharmaceuticals logo BioCryst Pharmaceuticals (NASDAQ:BCRX) has received an average rating of �Buy� from the twelve brokerages that are presently covering the company, Analyst Ratings Net reports. Two research analysts have rated the stock ...
Related articles »  
Mid Day Buzz: BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), PPG Industries ...
BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX) disclosed HHS agreement expired on June 30, according to its terms and as a result of completion of activities funded under the Agreement (13.10 +0.35).
BioCryst Pharmaceuticals Upgraded by Wells Fargo & Co. to Outperform (BCRX)
BioCryst Pharmaceuticals, Inc. logo BioCryst Pharmaceuticals (NASDAQ:BCRX) was upgraded by Wells Fargo & Co. from a �market perform� rating to an �outperform� rating in a research note issued on Monday, TheFlyOnTheWall.
Related articles »  
BioCryst Pharmaceuticals Given Consensus Recommendation of "Buy" by ...
In other BioCryst Pharmaceuticals news, CFO Thomas R. Staab II sold 3,125 shares of the company's stock in a transaction that occurred on Tuesday, July 1st.
Traders Stocks Alert: BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX ...
Lakeway, NY - (MARKET NEWS CALL) - 6/30/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Active Stocks: BioCryst Pharmaceuticals (NASDAQ:BCRX), PennantPark ...  Crazy Joys
Related articles »